Hamptons Homebuildi...
Health Care: Drugs
Dendreon Corp (DNDN: NASDAQ)
$3.89 -0.02 | -0.51%
05/24/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 325.53M | 341.61M | 48.06M | 101.00K |
| Cost of Sales | 158.67M | 96.87M | 10.90M | -5.31M |
| Gross Operating Profit | 166.86M | 244.75M | 37.16M | 5.41M |
| Selling, General, and Administrative Expenses | 317.13M | 361.34M | 235.76M | 38.56M |
| Research & Development | 74.64M | 74.29M | 75.94M | 61.59M |
| Operating Income before D & A (EBITDA) | -224.92M | -190.89M | -274.54M | -94.73M |
| Depreciation & Amortization | 69.22M | 62.22M | 17.62M | 5.31M |
| Interest Income | 1.34M | 1.42M | 1.14M | 964.00K |
| Other Income - Net | 101.00K | 180.00K | -147.28M | -118.76M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -338.36M | -290.10M | -438.30M | -217.84M |
| Interest Expense | 55.25M | 47.70M | 1.59M | 2.32M |
| Pre-Tax Income | -393.61M | -337.81M | -439.89M | -220.16M |
| Income Taxes | 0.00 | 0.00 | -411.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -393.61M | -337.81M | -439.48M | -220.16M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -393.61M | -337.81M | -439.48M | -220.16M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -393.61M | -337.81M | -439.48M | -220.16M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-347.94M | -299.22M | -439.48M | -220.16M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -393.61M | -337.81M | -439.48M | -220.16M |
| Basic EPS from Continuing Ops. | -2.65 | -2.31 | -3.18 | -2.04 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -2.65 | -2.31 | -3.18 | -2.04 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -2.65 | -2.31 | -3.18 | -2.04 |
| Basic Normalized Net Income/Share | -2.34 | -2.05 | -3.18 | -2.04 |
| EPS fr Continuing Ops. | -2.65 | -2.31 | -3.18 | -2.04 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -2.65 | -2.31 | -3.18 | -2.04 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -2.65 | -2.31 | -3.18 | -2.04 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-2.34 | -2.05 | -3.18 | -2.04 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DNDN
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorMost-Active Stocks for the ...
- Usersuresh45
- ContributorStocks Under-$10 Moving Hig...
- Usercarver
- UserZeca
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserLong Term Stock Picks
Latest DNDN Headlines from TheStreet
- Commit To Buy Dendreon At $2, Earn 26.5% 05.23.13 | 02:05 pm
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- A Dendreon Shareholder Voices His Frustration At Incompetent Directors 04.22.13 | 12:04 pm
- Oversold Conditions For Dendreon (DNDN) 04.18.13 | 04:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: It's Time to Pause 03.21.13 | 08:03 pm
- Shocker! Sell-Sider Admits Dendreon Buy Rating Was Mistake 03.06.13 | 10:03 am
- Why Expect More Price Swings From These 4 Biotechs 02.28.13 | 11:02 am
- Dendreon Corp (DNDN): Today's Featured Drugs Winner 01.28.13 | 05:01 pm
- Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocks 01.28.13 | 06:01 am
Press Releases for DNDN
- Dendreon Announces Securities Class Action Settlement - Business Wire 03.18.13 | 08:03 am
- Dendreon Announces Webcast Presentation At ROTH Conference - Business Wire 03.12.13 | 07:03 pm
- Dendreon Announces Fourth Quarter And 2012 Year End Results - Business Wire 02.25.13 | 07:02 am
- New PROVENGE® (sipuleucel-T) Data To Be Presented At 2013 American Society Of Clinical Oncology (ASCO) Genitourinary Cancers Symposium - Business Wire 02.13.13 | 08:02 am
- Dendreon To Host Conference Call On February 25 To Announce Fourth Quarter And Full Year 2012 Financial Results And Webcast Presentations At Upcoming Conferences - Business Wire 01.30.13 | 08:01 am
- Dendreon Announces Preliminary Fourth Quarter 2012 Revenues - Business Wire 01.07.13 | 09:01 am
- Dendreon Sells New Jersey Immunotherapy Manufacturing Facility - Business Wire 12.20.12 | 08:12 am
- Dendreon Announces Webcast Presentations At Upcoming Conferences - Business Wire 11.27.12 | 06:11 pm
- Dendreon Appoints Lindsay Rocco To Lead Corporate Communications - Business Wire 11.14.12 | 08:11 am
- Dendreon Announces Third Quarter 2012 Results - Business Wire 11.02.12 | 08:11 am
Partner Headlines for DNDN
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- Pre-Market Most Active for May 10, 2013 : DELL, DDD, APO, NOK, BAC, ING, NVS, PTIE, DNDN, NVDA, ERIC, MU - NASDAQ 05.10.13 | 12:05 pm
- Dendreon Earnings: Here’s Why the Stock is Rising Now - Wall St. Cheat Sheet 05.09.13 | 11:05 am
- Dendreon Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 05.08.13 | 07:05 am
- The Week Ahead: Host of Earnings on Tap; Investors Watching Anadarko, Activision, and Whole Foods - Benzinga 05.03.13 | 06:05 pm
- After Hours Most Active for Apr 19, 2013 : PBR/A, CRM, PPL, DOW, GILD, MS, QQQ, EMC, DTV, DNDN, SQNM, YHOO - NASDAQ 04.19.13 | 08:04 pm
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- 6 Reasons To Buy Dendreon Right Now - Seeking Alpha 03.09.13 | 08:03 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 02.11.13 | 09:02 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
